sigma tau acetyl l carnitine O-Acetyl-L-carnitine hydrochloride Carnitine Treatment → Organic Acidemia
Description
Cutaneous eruptions occur in 3% of individuals who receive carbamazepine and include diffuse erythema, exanthematous rash, urticaria, purpuric petechiae, or a mucocutaneous syndrome any of which can occur from day 8 to day 16 after treatment initiation.[2] Other dermatological adverse effects of carbamazepine include drug hypersensitivity, exfoliative dermatitis, erythroderma, erythema multiforme, and toxic epidermal necrolysis
S-()-ET 126: a potent and selective M1 antagonist in vitro and in vivo
L- -
It is a key element for the good function of the whole body
L-
